Dissociation of IGF2 and H19 imprinting in human brain

Brain Research

Volumn 810, Issue 1-2, 1998, Pages 1-8

  Pham, Nga V ^a   Nguyen, Mai T ^a   Hu, Ji Fan ^a   Vu, Thanh H ^a   Hoffman, Andrew R ^a  

^a Med Serv Geriatric Res Educ C   (United States)

Author keywords

Biallelic; Development; H19; Imprinting; Insulin like growth factor II

Indexed keywords

SOMATOMEDIN B;

ARTICLE; BRAIN; BRAIN REGION; GENE EXPRESSION; GENOME IMPRINTING; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION;

AGING; ALLELES; BRAIN CHEMISTRY; DNA; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INSULIN-LIKE GROWTH FACTOR II; PREGNANCY; PROMOTER REGIONS (GENETICS); RNA; TISSUE DISTRIBUTION;

EID: 0032501220     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00783-5     Document Type: Article

References (38)

1. Albrecht S., Waha A., Koch A., Kraus J.A., Goodyer C.G., Pietsch T. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma. J. Neuropathol. Exp. Neurol. 55:1996;1270-1276.
2. Albrecht U., Sutcliffe J.S., Cattanach B.M., Beechey C.V., Armstrong D., Eichele G., Beaudet A.L. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet. 17:1997;75-78.
3. Brandeis M., Kafri T., Ariel M., Chaillet J.R., McCarrey J., Rasin A., Ceder H. The ontogeny of allele-specific methylation associated with imprinted genes in the mouse. EMBO J. 12:1993;3669-3677.
4. Cheng B., Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12:1992;1558-1566.
5. DeChiara T.M., Efstratiadis A., Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 345:1990;78-80.
6. DeChiara T.M., Robertson E.J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:1991;849-859.
7. Eden S., Cedar H. Genomic imprinting. Action at a distance. Nature. 375:1995;7-16. [news; comment].
8. Ekstrom T.J., Cui H., Li X., Ohlsson R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development. 121:1995;309-316.
9. Feil R., Walter J., Allen N.D., Reik W. Developmental control of allelic methylation in the imprinted mouse igf2 and H19 genes. Development. 120:1994;2933-2943.
10. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumour-suppressor activity of H19 RNA. Nature. 365:1993;764-767.
11. Haselbacher G., Humbel R. Evidence for two species of insulin-like growth factor II (IGF II and big IGF II) in human spinal fluid. Endocrinology. 110:1982;1822-1824.
12. Haselbacher G.K., Schwab M.E., Pasi A., Humbel R.E. Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms. Proc. Natl. Acad. Sci. U.S.A. 82:1985;2153-2157.
13. Hu J.F., Oruganti H., Vu T.H., Hoffman A.R. Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation. Mol. Endocrinol. 12:1998;220-232.
14. Hu J.F., Vu T.H., Hoffman A.R. Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system. Mol. Endocrinol. 9:1995;628-636.
15. Hu J.F., Vu T.H., Hoffman A.R. Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. J. Biol. Chem. 271:1996;18253-18262.
16. Hu J.F., Vu T.H., Hoffman A.R. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. J. Biol. Chem. 272:1997;20715-20720.
17. Jinno Y., Ikeda Y., Yun K., Maw M., Masuzaki H., Fukuda H., Inuzuka K., Fujishita A., Ohtani Y., Okimoto T.et al. Establishment of functional imprinting of the H19 gene in human developing placentae. Nat. Genet. 10:1995;318-324.
18. Leighton P.A., Ingram R.S., Eggenschwiler J., Efstratiadis A., Tilghman S.M. Disruption of imprinting caused by deletion of the H19 gene region in mice [see comments]. Nature. 375:1995;34-39.
19. Leighton P.A., Saam J.R., Ingram R.S., Stewart C.L., Tilghman S.M. An enhancer deletion affects both H19 and Igf2 expression. Genes Dev. 9:1995;2079-2089.
20. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature. 366:1993;362-365.
21. Moulton T., Crenshaw T., Hao Y., Moosikasuwan J., Lin N., Dembitzer F., Hensle T., Weiss L., McMorrow L., Loew T.et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat. Genet. 7:1994;440-447.
22. Neff N.T., Prevette D., Houenou L.J., Lewis M.E., Glicksman M.A., Yin Q.W., Oppenheim R.W. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol. 24:1993;1578-1588.
23. Ohlsson R., Hedborg F., Holmgren L., Walsh C., Ekstrom T.J. Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development. 120:1994;361-368.
24. Olek A., Walter J. The pre-implantation ontogeny of the H19 methylation imprint. Nat. Genet. 17:1997;275-276.
25. Pedone P.V., Cosma M.P., Ungaro P., Colantuoni V., Bruni C.B., Zarrilli R., Riccio A. Parental imprinting of rat insulin-like growth factor II gene promoters is coordinately regulated. J. Biol. Chem. 269:1994;23970-23975.
26. Rainier S., Johnson L.A., Dobry C.J., Ping A.J., Grundy P.E., Feinberg A.P. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747-749.
27. Rougeulle C., Glatt H., Lalande M. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat. Genet. 17:1997;5-14. [letter].
28. Steenman M.J., Rainier S., Dobry C.J., Grundy P., Horon I.L., Feinberg A.P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat. Genet. 7:1994;433-439. published erratum appears in Nat. Genet. 1994 Oct. 8(2) 203.
29. Svensson K., Walsh C., Fundele R., Ohlsson R. H19 is imprinted in the choroid plexus and leptomeninges of the mouse foetus. Mech. Dev. 51:1995;31-37.
30. Tremblay K.D., Duran K.L., Bartolomei M.S. A 5′ 2-kilobase-pair region of the imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol. Cell Biol. 17:1997;4322-4329.
31. Vu T.H., Hoffman A. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor. J. Biol. Chem. 271:1996;9014-9023.
32. Vu T.H., Hoffman A.R. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature. 371:1994;714-717.
33. Vu T.H., Hoffman A.R. Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain [letter]. Nat. Genet. 17:1997;3-12.
34. Wang W.H., Duan J.X., Vu T.H., Hoffman A.R. Increased expression of the insulin-like growth factor II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J. Biol. Chem. 271:1996;27863-27870.
35. Zhang Y., Shields T., Crenshaw T., Hao Y., Moulton T., Tycko B. Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet. 53:1993;113-124.
36. Zhang Y., Tycko B. Monoallelic expression of the human H19 gene. Nat. Genet. 1:1992;40-44.
37. Zhuang H.X., Snyder C.K., Pu S.F., Ishii D.N. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp. Neurol. 140:1996;198-205.
38. Zumstein P.P., Luthi C., Humbel R.E. Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc. Natl. Acad. Sci. U.S.A. 82:1985;3169-3172.